(Q52208682)

English

Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.

scientific article published in January 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells. (English)

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

1 reference

based on heuristic

inferred from title

Mario Paolo Colombo

1

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

author name string

M Parenza

2

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

G Parmiani

3

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

publication date

1 January 1985

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

20

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

3

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

198-204

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

https://scigraph.springernature.com/pub.10.1007/bf00205576

0 references

T cell subset interactions in the regulation of syngeneic tumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human melanoma growth in nude mice by autologous, alloactivated peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phenotypic heterogeneity of antisyngeneic tumor killer cells (ASTK) generated in allogeneic mixed lymphocyte reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-mediated immunity: delayed-type hypersensitivity and cytotoxic responses are mediated by different T-cell subclasses

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of immunological eradication of a syngeneic guinea pig tumor. II. Effect of methotrexate treatment and T cell depletion of the recipient on adoptive immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential for specific cancer therapy with immune T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro elicitation of cytotoxic response against a nonimmunogenic murine tumor by allosensitization

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A critical examination of the foundations of immunotherapy for cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immune therapy in mice bearing poorly immunogenic metastases, using T lymphocytes stimulated in vitro against highly immunogenic mutant sublines

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passive adoptive immunotherapy of low-immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigenic Tumor Cell Variants Obtained with Mutagens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive chemoimmunotherapy of a moloney lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3851699

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00205576

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

1 reference

Europe PubMed Central

27 April 2018

http://europepmc.org/abstract/MED/3851699

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52208682&oldid=2132147472"